TAVI with the ACURATE neo transcatheter heart valve in special populations: A systematic review

Leonidas Koliastasis(National and Kapodistrian University of Athens), Konstantinos G. Toutouzas(Hippocration General Hospital), Georgios Benetos(Hippocration General Hospital), Maria Drakopoulou(Hippocration General Hospital), Αndreas Synetos(National and Kapodistrian University of Athens), Konstantinos Tsioufis(National and Kapodistrian University of Athens), Ioannis Doundoulakis(University General Hospital Attikon), Damianos G. Kokkinidis(Memorial Hospital of South Bend), Konstantina Aggeli(Hippocration General Hospital), George Latsios(Hippocration General Hospital), Dimitrios Tousoulis(National and Kapodistrian University of Athens), Anastasios Milkas(Athens Naval & Veterans Hospital)
Hellenic Journal of Cardiology
May 1, 2022
10.1016/j.hjc.2022.04.005
Cited by 3

Related Papers

Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York
|Metabolism|2020|901
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
|The Lancet|2018|775
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial
|The Lancet|2017|734
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial
|The Lancet|2020|586
Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity
|JAMA Cardiology|2019|418